Regencell Bioscience (RGC)
(Delayed Data from NSDQ)
$6.26 USD
-0.64 (-9.28%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $6.22 -0.04 (-0.64%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.26 USD
-0.64 (-9.28%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $6.22 -0.04 (-0.64%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
IMAX's Growth Prospects Hindered by Streaming Challenges
by Zacks Equity Research
On Dec 27, 2016, we issued an updated report on IMAX Corp. (IMAX).
AMC Entertainment's Carmike Buyout Gets Regulatory Nod
by Zacks Equity Research
AMC Entertainment Holdings Inc. (AMC), a leading global movie theater chain, received conditional regulatory approval for its proposed acquisition of a smaller rival Carmike Cinemas Inc. (CKEC).
Can Movie Theaters Gain from Rogue One: A Star Wars Story?
by Zacks Equity Research
Movie theater companies are already brimming with positivity regarding the release of Rogue One: A Star Wars Story on Dec 16.
Movie Theater Stocks Plummet on Premium VOD Concern
by Zacks Equity Research
Major film studios like Warner Brothers and Universal Pictures have announced that they are in discussions with movie theater chains for a new premium home window.